+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Alpha Mannosidosis Market by Treatment Type (Bone Marrow Transplant, Enzyme Replacement Therapy), Indication (Type I, Type II, Type III), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888601
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Alpha Mannosidosis Market size was estimated at USD 6.81 billion in 2023, USD 7.49 billion in 2024, and is expected to grow at a CAGR of 10.82% to reach USD 13.98 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alpha Mannosidosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alpha Mannosidosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alpha Mannosidosis Market, highlighting leading vendors and their innovative profiles. These include Chiesi Farmaceutici S.p.A., Cigna Corporation, CVS Caremark, Kamada Ltd., Orient Europharma (M) Sdn Bhd, and Talaris Therapeutics Inc.

Market Segmentation & Coverage

This research report categorizes the Alpha Mannosidosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Bone Marrow Transplant
    • Enzyme Replacement Therapy
  • Indication
    • Type I
    • Type II
    • Type III
  • End-User
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Alpha Mannosidosis Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alpha Mannosidosis Market?
  3. What are the technology trends and regulatory frameworks in the Alpha Mannosidosis Market?
  4. What is the market share of the leading vendors in the Alpha Mannosidosis Market?
  5. Which modes and strategic moves are suitable for entering the Alpha Mannosidosis Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Alpha Mannosidosis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness of alpha mannosidosis among population
5.1.1.2. Increasing investment to develop modern healthcare infrastructure
5.1.2. Restraints
5.1.2.1. High cost associated with alpha mannosidosis treatments
5.1.3. Opportunities
5.1.3.1. Emerging enzyme replacement therapy to treat rare genetic disorders
5.1.3.2. Rising product approvals for alpha mannosidosis medications
5.1.4. Challenges
5.1.4.1. Issues associated with dearth of skilled healthcare professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Alpha Mannosidosis Market, by Treatment Type
6.1. Introduction
6.2. Bone Marrow Transplant
6.3. Enzyme Replacement Therapy
7. Alpha Mannosidosis Market, by Indication
7.1. Introduction
7.2. Type I
7.3. Type II
7.4. Type III
8. Alpha Mannosidosis Market, by End-User
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics
9. Americas Alpha Mannosidosis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Alpha Mannosidosis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Alpha Mannosidosis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Chiesi Farmaceutici S.p.A.
13.1.2. Cigna Corporation
13.1.3. CVS Caremark
13.1.4. Kamada Ltd.
13.1.5. Orient Europharma (M) Sdn Bhd
13.1.6. Talaris Therapeutics Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ALPHA MANNOSIDOSIS MARKET RESEARCH PROCESS
FIGURE 2. ALPHA MANNOSIDOSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. ALPHA MANNOSIDOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ALPHA MANNOSIDOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ALPHA MANNOSIDOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALPHA MANNOSIDOSIS MARKET DYNAMICS
FIGURE 7. ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ALPHA MANNOSIDOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ALPHA MANNOSIDOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ALPHA MANNOSIDOSIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ALPHA MANNOSIDOSIS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ALPHA MANNOSIDOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ALPHA MANNOSIDOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALPHA MANNOSIDOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. ALPHA MANNOSIDOSIS MARKET SIZE, BY BONE MARROW TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ALPHA MANNOSIDOSIS MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. ALPHA MANNOSIDOSIS MARKET SIZE, BY TYPE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ALPHA MANNOSIDOSIS MARKET SIZE, BY TYPE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ALPHA MANNOSIDOSIS MARKET SIZE, BY TYPE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 13. ALPHA MANNOSIDOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ALPHA MANNOSIDOSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. CANADA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. MEXICO ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ALPHA MANNOSIDOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CHINA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. CHINA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. CHINA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. INDIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. INDIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. INDIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. JAPAN ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. JAPAN ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. THAILAND ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. THAILAND ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. DENMARK ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. DENMARK ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. DENMARK ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EGYPT ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. EGYPT ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. FINLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. FINLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. FRANCE ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ITALY ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ITALY ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. ITALY ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NORWAY ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. NORWAY ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. POLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. POLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. POLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. QATAR ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. QATAR ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. QATAR ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TURKEY ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. TURKEY ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM ALPHA MANNOSIDOSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM ALPHA MANNOSIDOSIS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM ALPHA MANNOSIDOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. ALPHA MANNOSIDOSIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 143. ALPHA MANNOSIDOSIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 144. ALPHA MANNOSIDOSIS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Chiesi Farmaceutici S.p.A.
  • Cigna Corporation
  • CVS Caremark
  • Kamada Ltd.
  • Orient Europharma (M) Sdn Bhd
  • Talaris Therapeutics Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.98 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal

Related Topics

Related Reports

Alpha Mannosidosis - Global Strategic Business Report - Product Image

Alpha Mannosidosis - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Global Alpha-Mannosidosis Market - Product Image

Global Alpha-Mannosidosis Market

  • Report
  • 200 Pages
  • Global
From
Alpha-mannosidosis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Alpha-mannosidosis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Alpha Mannosidosis Global Market Report 2024 - Product Image

Alpha Mannosidosis Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Antidiabetic Drugs Market by Type (Alpha-Glucosidase Inhibitors, Biguanides, DPP-IV (Dipeptidyl Peptidase) Inhibitors), Disease (Diabetes Mellitus Type 1, Diabetes Mellitus Type 2), Patient - Forecast 2024-2030 - Product Image

Global Antidiabetic Drugs Market by Type (Alpha-Glucosidase Inhibitors, Biguanides, DPP-IV (Dipeptidyl Peptidase) Inhibitors), Disease (Diabetes Mellitus Type 1, Diabetes Mellitus Type 2), Patient - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From

About the Alpha Mannosidosis Drug Market

Alpha Mannosidosis is a rare genetic disorder that affects the body's ability to break down certain sugars. Endocrine and Metabolic Disorders Drugs are used to treat this disorder. These drugs are designed to reduce the amount of sugar in the body, as well as to help the body break down the sugar more efficiently. Common drugs used to treat Alpha Mannosidosis include enzyme replacement therapy, gene therapy, and other medications. The Alpha Mannosidosis Drug market is a small but growing market, with a focus on providing treatments for this rare disorder. Companies in this market are focused on developing treatments that are safe and effective, as well as providing support for patients and their families. Some of the companies in this market include Genzyme, Shire, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.